Biotech Investing "Eleven clinical trials that will shape medicine in 2026" - BriaCell Phase 3 Trial Featured in Nature Medicine
Biotech Investing BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
Biotech Investing BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
Biotech Investing BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+ in Breast and Prostate Cancer Models
Biotech Investing BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
Biotech Investing BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+ for Breast Cancer
